{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:32:59Z","timestamp":1793773979751,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["BMS\/FW\/Nano\/2015-20580\/March15\/14\/govt"],"award-info":[{"award-number":["BMS\/FW\/Nano\/2015-20580\/March15\/14\/govt"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijbiomac.2020.12.204","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T13:18:32Z","timestamp":1610111912000},"page":"502-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"171","author":[{"given":"Shweta","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiya","family":"Mahtab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan Jalees","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Sandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yub Raj","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Kamra","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushama","family":"Talegaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s11095-016-2094-y","article-title":"Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis","volume":"34","author":"Kumar","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mehy.2016.04.026","article-title":"Nanofacilitated synergistic treatment for rheumatoid arthritis: a \u2018three-pronged\u2019 approach","volume":"92","author":"Pandey","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0015","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2478-2","article-title":"Co-delivery of teriflunomide and methotrexate from hydroxyapatite nanoparticles for the treatment of rheumatoid arthritis: in vitro characterization, pharmacodynamic and biochemical investigations","volume":"35","author":"Pandey","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejpb.2009.06.009","article-title":"Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance","volume":"73","author":"Butoescu","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10787-018-0459-z","article-title":"Predicting methotrexate resistance in rheumatoid arthritis patients","volume":"26","author":"Yu","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.colsurfb.2011.10.029","article-title":"Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer","volume":"99","author":"Choi","year":"2012","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116926","article-title":"Facile functionalization of teriflunomide-loaded nanoliposomes with chondroitin sulphate for the treatment of rheumatoid arthritis","volume":"250","author":"Mahtab","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-137-9-200211050-00007","article-title":"Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"Kremer","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10067-009-1349-y","article-title":"Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha","volume":"29","author":"De Stefano","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0050","first-page":"1","article-title":"Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities","author":"Kumar","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0055","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate","volume":"65","author":"Tian","year":"2007","journal-title":"Bull NYU Hosp Jt Dis."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0060","first-page":"177","article-title":"An update of teriflunomide for treatment of multiple sclerosis","volume":"9","author":"Oh","year":"2013","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0065","first-page":"251","article-title":"Design and evaluation of a novel transdermal patch containing diclofenac and teriflunomide for rheumatoid arthritis therapy","volume":"9","author":"Zhang","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0070","first-page":"695","article-title":"Leflunomide improves the clinical response in patients with active rheumatoid arthritis treated with methotrexate","volume":"21","author":"Van Riel","year":"2003","journal-title":"Clin. Exp. Rheumatol. (Testo Stamp.)"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","article-title":"Progress in intra-articular therapy","volume":"10","author":"Evans","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0080","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jbm.a.36765","article-title":"Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis","volume":"107","author":"Ain","year":"2019","journal-title":"J. Biomed. Mater. Res. Part A."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejps.2016.05.014","article-title":"Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: in vitro and in vivo evaluations","volume":"91","author":"Jafari","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"42","key":"10.1016\/j.ijbiomac.2020.12.204_bb0090","doi-asserted-by":"crossref","DOI":"10.2174\/1381612826666200523174108","article-title":"Biocompatible nanovesicular drug delivery systems with targeting potential for autoimmune diseases","volume":"26","author":"Neupane","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.colsurfb.2014.09.062","article-title":"Surface engineered nanostructured lipid carriers for targeting MDR tumor: part I. Synthesis, characterization and in vitro investigation","volume":"123","author":"Negi","year":"2014","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0100","doi-asserted-by":"crossref","first-page":"112649","DOI":"10.1016\/j.molliq.2020.112649","article-title":"PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: in vitro and in vivo assessment","volume":"303","author":"Singh","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0105","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/polym12112589","article-title":"Tailoring midazolam-loaded chitosan nanoparticulate formulation for enhanced brain delivery via intranasal route","volume":"12","author":"Shrestha","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0110","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab912d","article-title":"Polyoliposomes: novel polyol modified lipidic nanovesicles for dermal and transdermal delivery of drugs","author":"Suri","year":"2020","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0115","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/24\/41\/415102","article-title":"Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies","volume":"24","author":"Neupane","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4372","article-title":"Development and validation of stability indicating reversed-phase liquid chromatographic method for simultaneous quantification of methotrexate and teriflunomide in nanoparticles and marketed formulation","volume":"32","author":"Pandey","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2014.11.001","article-title":"Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment","volume":"477","author":"Neupane","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"47","key":"10.1016\/j.ijbiomac.2020.12.204_bb0130","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/abaf81","article-title":"Nanostructured lipid carriers potentiated oral delivery of raloxifene for breast cancer treatment","volume":"31","author":"Soni","year":"2020","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jddst.2019.03.008","article-title":"Quality by design driven development and optimization of teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: an in vitro and in vivo assessments","volume":"51","author":"Mahtab","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0140","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2217\/nnm-2020-0277","article-title":"Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo, in vivo and toxicity studies","volume":"15","author":"Mangla","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0145","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/10717544.2010.500635","article-title":"Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil","volume":"17","author":"Yadav","year":"2010","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0155","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1476-5381.2009.00468.x","article-title":"Enhancement of the anti-inflammatory and anti-arthritic effects of theophylline by a low dose of a nitric oxide donor or non-specific nitric oxide synthase inhibitor","volume":"158","author":"Gomaa","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0160","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ejp.620","article-title":"Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats","volume":"19","author":"Arora","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijbiomac.2017.01.077","article-title":"Production and characterization of bacterial cellulose membranes with hyaluronic acid from chicken comb","volume":"97","author":"de Oliveira","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.msec.2014.01.052","article-title":"Chemical functionalization of hyaluronic acid for drug delivery applications","volume":"38","author":"Vasi","year":"2014","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/cm0619398","article-title":"Hydrogen bonding interaction of poly (D, L-lactide)\/hydroxyapatite nanocomposites","volume":"19","author":"Zhou","year":"2007","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0180","doi-asserted-by":"crossref","first-page":"77968","DOI":"10.1039\/C6RA10659E","article-title":"Citrate-functionalized hydroxyapatite nanoparticles for pH-responsive drug delivery","volume":"6","author":"Verma","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0185","doi-asserted-by":"crossref","DOI":"10.1166\/sam.2015.2133","article-title":"Solid lipid nanoparticles for oral delivery of decitabine: formulation optimization, characterization, stability and ex-vivo gut permeation studies","volume":"7","author":"Neupane","year":"2015","journal-title":"Sci. Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/02652048.2017.1340355","article-title":"Lipid based nanoformulation of lycopene improves oral delivery: formulation optimization, ex vivo assessment and its efficacy against breast cancer","volume":"34","author":"Singh","year":"2017","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0195","first-page":"2013","article-title":"Macrophage repolarization using CD44-targeting hyaluronic acid\u2013polylactide nanoparticles containing curcumin","volume":"46","author":"Farajzadeh","year":"2018","journal-title":"Artif. Cells, Nanomedicine, Biotechnol."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0200","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/10717544.2018.1447050","article-title":"Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy","volume":"25","author":"Zhou","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0205","series-title":"Intra-Articular Hyaluronic Acid for Viscosupplementation in Osteoarthritis of the Hand, Shoulder, and Temporomandibular Joint: A Review of Clinical Effectiveness and Safety","author":"Tran","year":"2019"},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1302\/0301-620X.87B8.15083","article-title":"The effects of hyaluronic acid on articular chondrocytes","volume":"87","author":"Akmal","year":"2005","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40169-017-0180-3","article-title":"Recent advances in hyaluronic acid based therapy for osteoarthritis","volume":"7","author":"Bowman","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2020.12.204_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-15-253","article-title":"Inhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65","volume":"15","author":"Shi","year":"2014","journal-title":"BMC Musculoskelet. Disord."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020353848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020353848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:35:45Z","timestamp":1758875745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020353848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"alternative-id":["S0141813020353848"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.204","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}